Precigen Inc logo

Precigen Inc

$ 2.12 +0.07 (+3.41%) 04:00 PM EST
P/E:
At Loss
P/B:
8.17
Market Cap:
$ 459.57M
Enterprise V:
$ 519.22M
Volume:
974.87K
Avg Vol (2M):
1.15M
Also Trade In:
Volume:
974.87K
Market Cap $:
459.57M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.15M
Enterprise Value $:
519.22M
PB Ratio:
8.17
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals; Exemplar, and Trans Ova. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Name Current Vs Industry Vs History
Cash-To-Debt 0.56
Equity-to-Asset 0.17
Debt-to-Equity 3.73
Debt-to-EBITDA -2.84
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -7.6
Distress
Grey
Safe
Beneish M-Score -3.84
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 24.3
9-Day RSI 32.33
14-Day RSI 39.38
6-1 Month Momentum % 12.62
12-1 Month Momentum % -52.47

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.51
Quick Ratio 5.5
Cash Ratio 3.86
Days Inventory 70.45
Days Sales Outstanding 83.78
Days Payable 31.18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8.9

Financials (Next Earnings Date:2022-11-08 Est.)

PGEN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PGEN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 80.714
EPS (TTM) ($) -0.47
Beta 2.08
Volatility % 71.63
14-Day RSI 39.38
14-Day ATR ($) 0.199582
20-Day SMA ($) 2.4375
12-1 Month Momentum % -52.47
52-Week Range ($) 1.12 - 5.6
Shares Outstanding (Mil) 208.15

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Precigen Inc Filings

Document Form Filing Date
No Filing Data

Precigen Inc Analysis

Share your research

Headlines

See More
No news.